Logo image of TMO

THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TMO - US8835561023 - Common Stock

567.83 USD
+5.44 (+0.97%)
Last: 12/19/2025, 8:18:44 PM
567.83 USD
0 (0%)
After Hours: 12/19/2025, 8:18:44 PM
Fundamental Rating

5

Taking everything into account, TMO scores 5 out of 10 in our fundamental rating. TMO was compared to 57 industry peers in the Life Sciences Tools & Services industry. TMO has an excellent profitability rating, but there are some minor concerns on its financial health. TMO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year TMO was profitable.
TMO had a positive operating cash flow in the past year.
Each year in the past 5 years TMO has been profitable.
In the past 5 years TMO always reported a positive cash flow from operatings.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

TMO has a better Return On Assets (6.38%) than 84.21% of its industry peers.
TMO's Return On Equity of 12.88% is amongst the best of the industry. TMO outperforms 85.96% of its industry peers.
With a decent Return On Invested Capital value of 7.21%, TMO is doing good in the industry, outperforming 77.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TMO is significantly below the industry average of 13.99%.
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROIC 7.21%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TMO has a better Profit Margin (15.02%) than 84.21% of its industry peers.
In the last couple of years the Profit Margin of TMO has remained more or less at the same level.
With an excellent Operating Margin value of 18.40%, TMO belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.
TMO's Operating Margin has improved in the last couple of years.
The Gross Margin of TMO (41.43%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TMO has remained more or less at the same level.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMO is destroying value.
TMO has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TMO has been reduced compared to 5 years ago.
The debt/assets ratio for TMO has been reduced compared to a year ago.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

The Debt to FCF ratio of TMO is 5.84, which is a neutral value as it means it would take TMO, 5.84 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.84, TMO is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
TMO has a Debt/Equity ratio of 0.62. This is a neutral value indicating TMO is somewhat dependend on debt financing.
TMO has a Debt to Equity ratio of 0.62. This is in the lower half of the industry: TMO underperforms 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Altman-Z N/A
ROIC/WACC0.68
WACC10.61%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

TMO has a Current Ratio of 1.50. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
TMO has a worse Current ratio (1.50) than 75.44% of its industry peers.
TMO has a Quick Ratio of 1.11. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
TMO has a worse Quick ratio (1.11) than 71.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.11
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.53% over the past year.
Measured over the past years, TMO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.12% on average per year.
The Revenue has been growing slightly by 3.22% in the past year.
TMO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%

3.2 Future

The Earnings Per Share is expected to grow by 9.66% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.65% on average over the next years.
EPS Next Y5.07%
EPS Next 2Y6.62%
EPS Next 3Y7.69%
EPS Next 5Y9.66%
Revenue Next Year3.54%
Revenue Next 2Y4.24%
Revenue Next 3Y4.66%
Revenue Next 5Y4.65%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.35, which means the current valuation is very expensive for TMO.
Based on the Price/Earnings ratio, TMO is valued a bit cheaper than 78.95% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.39. TMO is around the same levels.
The Price/Forward Earnings ratio is 22.85, which indicates a rather expensive current valuation of TMO.
TMO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TMO is cheaper than 78.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of TMO to the average of the S&P500 Index (23.84), we can say TMO is valued inline with the index average.
Industry RankSector Rank
PE 25.35
Fwd PE 22.85
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TMO indicates a somewhat cheap valuation: TMO is cheaper than 73.68% of the companies listed in the same industry.
68.42% of the companies in the same industry are more expensive than TMO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.92
EV/EBITDA 22.49
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMO does not grow enough to justify the current Price/Earnings ratio.
TMO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5
PEG (5Y)2.09
EPS Next 2Y6.62%
EPS Next 3Y7.69%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.31%, TMO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.09, TMO pays a better dividend. On top of this TMO pays more dividend than 85.96% of the companies listed in the same industry.
With a Dividend Yield of 0.31, TMO pays less dividend than the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

On average, the dividend of TMO grows each year by 15.42%, which is quite nice.
TMO has paid a dividend for at least 10 years, which is a reliable track record.
TMO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.42%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

TMO pays out 9.48% of its income as dividend. This is a sustainable payout ratio.
The dividend of TMO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.62%
EPS Next 3Y7.69%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (12/19/2025, 8:18:44 PM)

After market: 567.83 0 (0%)

567.83

+5.44 (+0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners92.88%
Inst Owner Change-0.3%
Ins Owners0.09%
Ins Owner Change4.79%
Market Cap213.34B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts81.29
Price Target631.27 (11.17%)
Short Float %1.36%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend1.52
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years7
Div Non Decr Years12
Ex-Date12-15 2025-12-15 (0.43)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)1.08%
PT rev (3m)11.35%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-0.84%
EPS NY rev (1m)0.05%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.47%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 25.35
Fwd PE 22.85
P/S 4.88
P/FCF 34.92
P/OCF 27.89
P/B 4.18
P/tB N/A
EV/EBITDA 22.49
EPS(TTM)22.4
EY3.94%
EPS(NY)24.85
Fwd EY4.38%
FCF(TTM)16.26
FCFY2.86%
OCF(TTM)20.36
OCFY3.59%
SpS116.41
BVpS135.81
TBVpS-38.61
PEG (NY)5
PEG (5Y)2.09
Graham Number261.62
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROCE 9.13%
ROIC 7.21%
ROICexc 7.52%
ROICexgc 33.37%
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
FCFM 13.97%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
ROICexc(3y)8.22%
ROICexc(5y)9.55%
ROICexgc(3y)40.87%
ROICexgc(5y)46.64%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Debt/EBITDA 2.94
Cap/Depr 55.1%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 70.55%
Profit Quality 93%
Current Ratio 1.5
Quick Ratio 1.11
Altman-Z N/A
F-Score8
WACC10.61%
ROIC/WACC0.68
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y5.07%
EPS Next 2Y6.62%
EPS Next 3Y7.69%
EPS Next 5Y9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year3.54%
Revenue Next 2Y4.24%
Revenue Next 3Y4.66%
Revenue Next 5Y4.65%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year15.34%
EBIT Next 3Y8.99%
EBIT Next 5Y9.16%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%

THERMO FISHER SCIENTIFIC INC / TMO FAQ

What is the ChartMill fundamental rating of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMO.


Can you provide the valuation status for THERMO FISHER SCIENTIFIC INC?

ChartMill assigns a valuation rating of 4 / 10 to THERMO FISHER SCIENTIFIC INC (TMO). This can be considered as Fairly Valued.


What is the profitability of TMO stock?

THERMO FISHER SCIENTIFIC INC (TMO) has a profitability rating of 7 / 10.


What is the valuation of THERMO FISHER SCIENTIFIC INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for THERMO FISHER SCIENTIFIC INC (TMO) is 25.35 and the Price/Book (PB) ratio is 4.18.


Can you provide the expected EPS growth for TMO stock?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TMO) is expected to grow by 5.07% in the next year.